As of early 2026, 60,000 girls in Ukraine have received their free HPV vaccine — a landmark milestone in what is the country’s first-ever organised cancer prevention campaign since independence. The push follows Ukraine’s official addition of the HPV vaccine to its National Immunisation Calendar in March 2026.
Key Milestones at a Glance
One Vaccine, Many Diseases Prevented
Ukraine’s programme uses the 9-valent HPV vaccine, which targets nine HPV strains responsible for approximately 99% of cervical cancer cases. But cervical cancer is only part of the picture. The same vaccine provides protection against:
- Cervical cancer — the primary HPV-related malignancy in women
- Vulvar, vaginal, and anal cancers
- Oropharyngeal (throat) cancer
- Anogenital warts — highly transmissible, affecting both sexes
This makes the HPV vaccine one of the rare examples of a single vaccine delivering multi-disease, multi-cancer prevention — a compelling case for the broadest possible uptake.
Ukraine’s First-Ever Cancer Prevention Campaign
The significance of this moment goes beyond the numbers. This is the first organised cancer prevention campaign in the history of independent Ukraine. The programme targets girls aged 12–13 through schools — reaching them before typical first exposure to the virus. Since the primary target age falls below the threshold at which children in Ukraine can independently consent to medical procedures, school outreach engages parents and guardians directly. The strong 82% parental approval rate provides a solid foundation to build upon.
How Leading Countries Are Addressing HPV
Ukraine is not alone in this fight. Several high-income countries have been running structured HPV programmes for nearly two decades — with striking results.
| Country | Started | Target group | Age group | Goal / Expected outcome |
|---|---|---|---|---|
| 🇦🇺 Australia | 2007 (girls) 2013 (boys) |
Girls & Boys | 12–13 (routine) up to 25 (catch-up) |
On track to become the first country in the world to eliminate cervical cancer as a public health problem — projected by 2028 |
| 🇬🇧 United Kingdom | 2008 (girls) 2019 (boys) |
Girls & Boys | 12–13 (Year 8) up to 25 (catch-up) |
Eliminate cervical cancer by 2040; 90% vaccination coverage target by 2030. 2023/24 uptake: 77% girls, 71% boys |
| 🇩🇪 Germany | 2007 (girls) 2018 (boys) |
Girls & Boys | 9–14 (routine) up to 17 (catch-up) |
WHO 90-70-90 targets by 2030; current coverage ~51% (girls), ~17% (boys) — significant room for improvement |
| 🇯🇵 Japan | 2009 (girls) Suspended 2013–2022 |
Girls (primarily) | 12–16 (routine) up to 25 (catch-up) |
Recovering from a decade-long suspension; national catch-up campaign (2022–2025) aiming to rebuild a lost generation of coverage |
| 🇺🇦 Ukraine | 2026 | Girls | 12–13 (routine) | First cancer prevention campaign in the country’s history; 15% of the primary cohort vaccinated so far |
The Challenge Ahead
Sixty thousand vaccinations is a headline worth celebrating — and 15% initial coverage for a brand-new programme is not nothing. But context matters: once you look beyond the narrow 12–13 primary cohort and consider all adolescents and young people who could benefit from catch-up vaccination, the actual population-level coverage is far less impressive. The gap between ambition and reach remains enormous.
Closing it will require sustained, coordinated effort from public health authorities, NGOs, healthcare providers, and communities — shifting Ukraine toward a genuinely preventive healthcare culture, not just a reactive one. The HPV campaign is a piece of a larger puzzle. Just this week, Ukraine announced the largest-ever expansion of its Affordable Drugs programme for cardiovascular diseases — another massively preventable group of conditions responsible for 60% of the country’s mortality. The direction of travel is right. The pace now needs to match the ambition.
Source: Ministry of Health of Ukraine — Vaccination coverage positive dynamics, 2025